NCT04243473 2026-03-03
Biopsy Collection for Men Undergoing Brachytherapy for Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Withdrawn
Clinical Trials
168 trialsNCT05014295 2026-02-24
Patient Recall of Cancer Screening and Diagnosis
Case Comprehensive Cancer Center
Phase NA Withdrawn
NCT03027986 2026-02-17
PROTOMEN
University Hospital, Rouen
Phase NA Withdrawn
NCT03274778 2025-11-18
Effect of Ruxolitinib on Tumor Infiltrating Myeloid Cells
Oncology Institute of Southern Switzerland
Phase NA Withdrawn
NCT04910425 2025-10-21
PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer
Northwestern University
Phase 2 Withdrawn
NCT04645810 2025-10-15
A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence
University of Rochester
Phase NA Withdrawn
NCT05046782 2025-09-30
Abbreviated Biparametric MRI (RSI + T2WI) for Prostate Cancer Detection: Correlation With Histopathology
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT06527690 2025-09-29
REPRESENTATION
Latin American Cooperative Oncology Group
Phase 2 Withdrawn
NCT06528210 2025-09-23
Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer
OHSU Knight Cancer Institute
Phase 2 Withdrawn
NCT02869282 2025-09-17
CHEMOPROST
Institut Bergonié
Withdrawn
NCT03477864 2025-04-29
Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate Cancer
Thomas Jefferson University
Phase 1 Withdrawn
NCT03581500 2025-04-23
Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Patients With Prostate Cancer
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT05815316 2025-04-13
18F-PSMA PET/MRI for the Diagnosis of Clinically Significant Prostate Cancer
IRCCS San Raffaele
Phase 2 Withdrawn
NCT06094842 2025-04-01
Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer
Fred Hutchinson Cancer Center
Phase 1 Withdrawn
NCT04495959 2025-01-08
Dynamic Whole Body PET/ MRI
British Columbia Cancer Agency
Withdrawn
NCT05568537 2025-01-03
Prostate MRI and Pylarify PSMA PET/CT
Corewell Health East
Phase 4 Withdrawn
NCT01350180 2024-12-10
Assessing DNA Changes in High Risk Prostate Cancer to Determine Prognosis
Sir Mortimer B. Davis - Jewish General Hospital
Withdrawn
NCT02588404 2024-12-10
The Predictive Value of TMPRSS2-ERG Fusion in High Risk Prostate Cancer Patient
Sir Mortimer B. Davis - Jewish General Hospital
Withdrawn
NCT02588846 2024-11-18
KOALA
Royal North Shore Hospital
Phase NA Withdrawn
NCT06218667 2024-10-31
A Study of Copanlisib in Combination with Degarelix in People with Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 1/2 Withdrawn
NCT04312191 2024-10-08
Using Meditation for Oncology Anxiety
Geisinger Clinic
Phase NA Withdrawn
NCT05707182 2024-09-25
18F-rhPSMA-7.3 PET/MRI in Prostate Cancer Active Surveillance: a Pilot Study
University of Alabama at Birmingham
Phase EARLY_PHASE1 Withdrawn
NCT03459755 2024-09-19
Evaluating Race Specific AGE Accumulation As a Behavioral Biomarker Prostate Cancer Survivors
Medical University of South Carolina
Phase NA Withdrawn
NCT06329830 2024-09-19
LUNAAR
Baptist Health South Florida
Phase 1/2 Withdrawn
NCT05415696 2024-08-09
Prostatic Artery Embolization for the Treatment of Lower Urinary Tract Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy
Stanford University
Phase NA Withdrawn
NCT02921373 2024-07-24
TRACK
Western University, Canada
Phase 1 Withdrawn
NCT03035357 2024-05-03
Neoadjuvant Listeria or Daratumumab in Prostate Cancer
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT04243941 2024-03-21
PSMA-PET/MRI Low- and Intermediate-Risk Prostate Cancer
UNC Lineberger Comprehensive Cancer Center
Phase 2 Withdrawn
NCT03909893 2024-03-19
ARTGU
University Health Network, Toronto
Phase NA Withdrawn
NCT05034562 2024-03-07
Gallium-68 PSMA-11 PET in Participants With Prostate Cancer
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT05156372 2024-02-26
HIIT PCa
The University of Texas Health Science Center at San Antonio
Phase NA Withdrawn
NCT03970863 2024-02-09
Focal Therapy for Localized Prostate Cancer
China Medical University Hospital
Withdrawn
NCT04304079 2024-01-23
A Novel Augmented Reality System (ARssist) for the Assistant Surgeon in Robotic Assisted Surgery
Chinese University of Hong Kong
Phase NA Withdrawn
NCT05238831 2024-01-23
SMMART Adaptive Clinical Treatment (ACT) Trial
OHSU Knight Cancer Institute
Phase EARLY_PHASE1 Withdrawn
NCT05035732 2024-01-18
A Prospective Pilot Study for the Evaluation of 18F- Fluciclovine PET/MRI in Radio-recurrent Prostate Cancer (RRPC-PET/MRI Study)
M.D. Anderson Cancer Center
Phase NA Withdrawn
NCT00323180 2024-01-11
Investigation of Protein Biomarkers of Prostate Cancer
University of New Mexico
Withdrawn
NCT00323388 2024-01-11
Identification of Risk Allels for Prostate Cancer
University of New Mexico
Withdrawn
NCT06159998 2023-12-07
New Markers for Treatment Response to Radiotherapy in Prostate Cancer
University of Basel
Withdrawn
NCT05567679 2023-09-22
A Study of Tazemetostat (Tazverik) Before Prostatectomy in Men With Prostate Cancer
Cedars-Sinai Medical Center
Phase EARLY_PHASE1 Withdrawn
NCT05771896 2023-09-14
CARE
GenesisCare USA
Phase 3 Withdrawn
NCT05098327 2023-08-15
Pioglitazone and Insulin Resistance in ADT
State University of New York at Buffalo
Phase 3 Withdrawn
NCT01555632 2023-08-14
Atorvastatin Calcium in Preventing Metabolic Syndrome in Prostate Cancer Patients Receiving Androgen-Deprivation Therapy
University of Nebraska
Phase NA Withdrawn
NCT04781374 2023-07-11
Neratinib in Patients With Metastatic Castration-Resistant Prostate Cancer
Beth Israel Deaconess Medical Center
Phase 2 Withdrawn
NCT04995978 2023-06-23
Insulin Resistance and Androgen Deprivation Therapy
St. Louis University
Phase 2 Withdrawn
NCT04483414 2023-05-19
68Ga PSMA-11 PET/CT in Recurrent Prostate Cancer
University of Texas Southwestern Medical Center
Phase 2 Withdrawn
NCT04658849 2023-05-15
Insulin Resistance Following ADT for Prostate CA
St. Louis University
Phase EARLY_PHASE1 Withdrawn
NCT05245435 2023-03-20
Diagnostic and Prognostic Accuracy of FDHT-PET and Liquid Biopsies in Prostate Cancer
Medical University of Vienna
Phase NA Withdrawn
NCT04797078 2023-03-10
FLAPP
Karolinska Institutet
Phase NA Withdrawn
NCT05705700 2023-02-27
Biomarker Study of in Men With PSA Progression on Abi for CR or CS PC (Bio-STAMP)
Masonic Cancer Center, University of Minnesota
Phase 2 Withdrawn
NCT03987568 2022-12-21
Characterize Tumor Hypoxia by Magnetic Resonance Imaging
Wake Forest University Health Sciences
Phase NA Withdrawn